Plasma lipidomics reveals potential lipid markers of major depressive disorder (scientific article published on 25 July 2016)

Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association

Q38564070

Alterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stress.

Q39195135

Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing

Q39547930

Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study

Q43497199

Hypertriglyceridemia as a cardiovascular risk factor

Q44268486

Clinical diagnosis of depression in primary care: a meta-analysis

Q44323103

Lipid and lipoprotein levels in depressive disorders with melancholic feature or atypical feature and dysthymia

Q44900384

Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress

Q46513792

Brain and mind: a challenge for WHO.

Q48284196

Urinary metabonomic study using a CUMS rat model of depression.

Q48722707

Plasma metabonomics as a novel diagnostic approach for major depressive disorder.

Q48760949

Alterations in phosphatidylinositol 3-kinase activity and PTEN phosphatase in the prefrontal cortex of depressed suicide victims.

Q48888353

Triglycerides and the Risk of Coronary Heart Disease

Q57267183

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease

Q27013591

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Q29547223

Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression

Q33402521

DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression

Q34017635

Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.

Q34386877

Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)

Q35023431

Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry

Q35580090

Depression increases the onset of cardiovascular disease over and above other determinants in older primary care patients, a cohort study

Q35627133

Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum.

Q35861541

A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies

Q36119909

Cortical inhibitory and excitatory correlates of depression severity in children and adolescents

Q36387139

Identification and validation of urinary metabolite biomarkers for major depressive disorder

Q36508139

Analytical strategies in lipidomics and applications in disease biomarker discovery

Q37398347

G protein-linked signaling pathways in bipolar and major depressive disorders

Q37408559

P433

issue

P407

language of work or name

English

Q1860

P1104

number of pages

P304

page(s)

6497-6507

P577

publication date

2016-07-25

P1433

published in

Analytical and Bioanalytical Chemistry

Q2845280

P1476

title

Plasma lipidomics reveals potential lipid markers of major depressive disorder

P478

volume

408

Reverse relations

cites work (P2860)

Q64249316	A Data Science-Based Analysis Points at Distinct Patterns of Lipid Mediator Plasma Concentrations in Patients With Dementia
Q89848830	A multi-omics investigation of the molecular characteristics and classification of six metabolic syndrome relevant diseases
Q33704099	Biomarkers for depression: recent insights, current challenges and future prospects
Q98901075	Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors
Q92857119	Examining the Influence of Early Life Stress on Serum Lipid Profiles and Cognitive Functioning in Depressed Patients
Q63433311	Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children
Q60938815	Inverse Phosphatidylcholine/Phosphatidylinositol Levels as Peripheral Biomarkers and Phosphatidylcholine/Lysophosphatidylethanolamine-Phosphatidylserine as Hippocampal Indicator of Postischemic Cognitive Impairment in Rats
Q58122230	Lipidomics in Major Depressive Disorder
Q38740021	Lipidomics: Prospects from a technological perspective.
Q97519954	Longitudinal Intravital Microscopy Reveals Axon Degeneration Concomitant With Inflammatory Cell Infiltration in an LPC Model of Demyelination
Q46248790	Plasma sphingolipids and depressive symptoms in coronary artery disease
Q50348510	Serum profile changes in postpartum women with a history of childhood maltreatment: a combined metabolite and lipid fingerprinting study.
Q37729874	The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants
Q94592321	The gut microbiome modulates gut-brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression

P356	DOI	10.1007/S00216-016-9768-5
P2888	exact match	https://scigraph.springernature.com/pub.10.1007/s00216-016-9768-5
P698	PubMed publication ID	27457104